Podcast
Questions and Answers
What is the patient's height in centimeters?
What is the patient's height in centimeters?
- 172cm
- 175cm
- 170cm (correct)
- 168cm
What is the patient's weight in kilograms?
What is the patient's weight in kilograms?
- 50 kg
- 58 kg
- 54 kg (correct)
- 60 kg
Why was the patient taking a nonsteroidal anti-inflammatory drug (NSAID)?
Why was the patient taking a nonsteroidal anti-inflammatory drug (NSAID)?
- To relieve occasional back pain and stiffness (correct)
- To treat gastroesophageal reflux disease
- To improve her diet
- To prevent osteoporosis
What is the patient's family history regarding osteoporosis?
What is the patient's family history regarding osteoporosis?
What is the patient's T score at the spine?
What is the patient's T score at the spine?
Why was the patient referred for BMD testing?
Why was the patient referred for BMD testing?
What is indicated by her T-score?
What is indicated by her T-score?
What is the purpose of the FRAX tool?
What is the purpose of the FRAX tool?
Why is ibandronate not a suitable drug to manage her case?
Why is ibandronate not a suitable drug to manage her case?
What is a risk factor for osteoporosis mentioned in the text?
What is a risk factor for osteoporosis mentioned in the text?
What is considered a high fracture risk according to FRAX?
What is considered a high fracture risk according to FRAX?
What is a potential result of FRAX assessment in this patient?
What is a potential result of FRAX assessment in this patient?
What is typically used to evaluate bone resorption during antiresorptive therapy?
What is typically used to evaluate bone resorption during antiresorptive therapy?
What is the typical duration of treatment before considering a drug holiday?
What is the typical duration of treatment before considering a drug holiday?
Why is a drug holiday recommended after long-term bisphosphonate therapy?
Why is a drug holiday recommended after long-term bisphosphonate therapy?
What is the effect of bisphosphonates on bone density after discontinuation?
What is the effect of bisphosphonates on bone density after discontinuation?
What is the purpose of measuring bone turnover markers (BTMs) at 3-6 months after initiation of treatment?
What is the purpose of measuring bone turnover markers (BTMs) at 3-6 months after initiation of treatment?
What is the recommended drug class for a patient with high fracture risk according to 2020 AACE/ACE guidelines?
What is the recommended drug class for a patient with high fracture risk according to 2020 AACE/ACE guidelines?
Why was the patient prescribed I.V bisphosphonates (zoledronic acid) instead of oral bisphosphonates?
Why was the patient prescribed I.V bisphosphonates (zoledronic acid) instead of oral bisphosphonates?
What is a common adverse effect of I.V bisphosphonates?
What is a common adverse effect of I.V bisphosphonates?
What is a possible way to evaluate therapeutic outcomes in patients with high fracture risk?
What is a possible way to evaluate therapeutic outcomes in patients with high fracture risk?
How often can central DXA BMD measurements be obtained for monitoring bone loss and treatment response?
How often can central DXA BMD measurements be obtained for monitoring bone loss and treatment response?
What is another possible adverse effect of I.V bisphosphonates?
What is another possible adverse effect of I.V bisphosphonates?